Table 1 Variables associated with baseline miR-1254.

From: Circulating miR-1254 predicts ventricular remodeling in patients with ST-Segment-Elevation Myocardial Infarction: A cardiovascular magnetic resonance study

 

Overall (n = 70)

Lower third (n = 23)

Middle third (n = 23)

Upper third (n = 24)

P-value

Age, years

60 (49–68)

63 (49–71)

54 (48–60)

61 (50–68)

0.101

Male sex

50 (71.4)

18 (78.3)

15 (65.2)

17 (70.8)

0.641

Medical history

  Arterial hypertension

38 (54.3)

11 (47.8)

12 (52.2)

15 (62.5)

0.583

  Diabetes mellitus

16 (22.9)

4 (17.4)

5 (21.7)

7 (29.2)

0.681

  Dyslipidemia

30 (42.9)

10 (43.5)

8 (34.8)

12 (50.0)

0.572

  Smoker

45 (64.3)

14 (60.9)

17 (73.9)

14 (58.3)

0.493

  Prior IHD

4 (5.7)

3 (13.0)

1 (4.4)

0

0.120

  Anterior infarction

33 (47.1)

12 (52.2)

11 (47.8)

10 (41.7)

0.768

  Grace score

133 (110–155)

133 (99–151)

126 (99–150)

140 (127–159)

0.330

  TIMI risk score

2 (1–4)

2 (1–4)

2 (1–3)

3 (1–4)

0.504

  Killip-kimbal class ≥ II

13 (18.6)

4 (17.4)

5 (21.7)

4 (16.7)

0.930

  Time from chest pain onset to reperfusion

266 (150–390)

272 (106–420)

270 (180–329)

229 (150–405)

0.991

Laboratory values

  Peak hs-cTnT, ng/ml

2794 (1589–4943)

2781 (1105–3675)

3883 (2279–7120)

2499 (1434–3355)

0.091

  NT-proBNP, pg/ml

207 (67–501)

285 (52–744)

221 (131–390)

144 (56–403)

0.603

Treatment at discharge

  ACEI/ARB

58 (82.9)

21 (91.3)

19 (82.6)

18 (75.0)

0.359

  Betablockers

54 (77.1)

21 (91.3)

15 (65.2)

18 (75.0)

0.114

  Aldosterone receptor blockers

11 (15.7)

5 (21.7)

3 (13.0)

3 (12.5)

0.711

  Loop diuretics

5 (7.1)

2 (8.7)

1 (4.4)

2 (8.3)

1.000

  Statins

63 (90.0)

22 (95.7)

20 (87.0)

21 (87.5)

0.686

  1. Data are presented as n (%) or median (IQR). IHD, ischemic heart disease; hs-cTnT, high sensitive troponin T; NT-proBNP, amino-terminal pro-brain natriuretic peptide; ACE, angiotensin-converting enzyme; ARB, angiotensin II receptor blocker.